BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34837064)

  • 21. Mesenchymal chondrosarcomas showing immunohistochemical evidence of rhabdomyoblastic differentiation: a potential diagnostic pitfall.
    Folpe AL; Graham RP; Martinez A; Schembri-Wismayer D; Boland J; Fritchie KJ
    Hum Pathol; 2018 Jul; 77():28-34. PubMed ID: 29559236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population.
    Ramanayake N; Vargas AC; Talbot J; Bonar F; Wong DD; Wong D; Mahar A; Karim R; Luk PP; Selinger C; Sioson L; Gill AJ; Maclean F
    Pathology; 2021 Oct; 53(6):705-712. PubMed ID: 33640159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraparenchymal mesenchymal chondrosarcoma of the frontal lobe--a case report and molecular detection of specific gene fusions from archival FFPE sample.
    Sajjad EA; Sikora K; Paciejewski T; Garbicz F; Paskal W; Szacht M; Grajkowska W; Włodarski PK
    Clin Neuropathol; 2015; 34(5):288-93. PubMed ID: 25907264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NKX3.1 immunohistochemistry and methylome profiling in mesenchymal chondrosarcoma: additional diagnostic value for a well-defined disease?
    Glauser S; Ameline B; Andrei V; Harder D; Pauli C; Trautmann M; Hartmann W; Baumhoer D
    Pathology; 2023 Aug; 55(5):621-628. PubMed ID: 37225644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NcoA2-Dependent Inhibition of HIF-1α Activation Is Regulated via AhR.
    Tsai CH; Li CH; Liao PL; Cheng YW; Lin CH; Huang SH; Kang JJ
    Toxicol Sci; 2015 Dec; 148(2):517-30. PubMed ID: 26350169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes.
    Jin Y; Möller E; Nord KH; Mandahl N; Von Steyern FV; Domanski HA; Mariño-Enríquez A; Magnusson L; Nilsson J; Sciot R; Fletcher CD; Debiec-Rychter M; Mertens F
    Genes Chromosomes Cancer; 2012 May; 51(5):510-20. PubMed ID: 22337624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary mesenchymal chondrosarcoma of the lung.
    Perry WR; McHugh JB; Konopka KE
    Pathol Int; 2023 Apr; 73(4):170-172. PubMed ID: 36752330
    [No Abstract]   [Full Text] [Related]  

  • 28. Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma.
    Nyquist KB; Panagopoulos I; Thorsen J; Haugom L; Gorunova L; Bjerkehagen B; Fosså A; Guriby M; Nome T; Lothe RA; Skotheim RI; Heim S; Micci F
    PLoS One; 2012; 7(11):e49705. PubMed ID: 23185413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mesenchymal chondrosarcoma with aberrant nuclear expression of STAT6: a potential diagnostic pitfall.
    Broggi G; Mazzucchelli M; Covello R; Casini B; Barbagallo GMV; Salvatorelli L; Magro G
    Pathol Res Pract; 2022 Apr; 232():153803. PubMed ID: 35217266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hybrid sclerosing epithelioid fibrosarcoma/low grade fibromyxoid sarcoma arising in the small intestine with distinct HEY1-NCOA2 gene fusion.
    Murshed KA; Ammar A
    Pathology; 2020 Aug; 52(5):607-610. PubMed ID: 32564922
    [No Abstract]   [Full Text] [Related]  

  • 31. Rare malignant primary spinal intradural extramedullary mesenchymal chondrosarcoma: a case report and literature review.
    Wang Y; Meng X; Liu W; Wang H; Xin T
    Transl Cancer Res; 2022 Sep; 11(9):3371-3378. PubMed ID: 36237254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma.
    Morioka H; Takahashi S; Araki N; Sugiura H; Ueda T; Takahashi M; Yonemoto T; Hiraga H; Hiruma T; Kunisada T; Matsumine A; Susa M; Nakayama R; Nishimoto K; Kikuta K; Horiuchi K; Kawai A
    BMC Cancer; 2016 Jul; 16():479. PubMed ID: 27418251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mesenchymal chondrosarcoma in central nervous system: a clinicopathological analysis].
    Huang Q; Chen YP; Song FL; Zheng LM; Liu XY; Zhang S; Wang XF
    Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):870-875. PubMed ID: 34344069
    [No Abstract]   [Full Text] [Related]  

  • 34. Hairy/enhancer-of-split related with YRPW motif protein 1 promotes osteosarcoma metastasis via matrix metallopeptidase 9 expression.
    Tsuru A; Setoguchi T; Matsunoshita Y; Nagao-Kitamoto H; Nagano S; Yokouchi M; Maeda S; Ishidou Y; Yamamoto T; Komiya S
    Br J Cancer; 2015 Mar; 112(7):1232-40. PubMed ID: 25742474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary mesenchymal chondrosarcoma of the kidney without
    Yamagishi A; Ichiyanagi O; Naito S; Ito H; Kabasawa T; Yamakawa M; Tsuchiya N
    Oncol Lett; 2020 Jan; 19(1):885-891. PubMed ID: 31897203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soft tissue angiofibroma: Clinicopathologic, immunohistochemical and molecular analysis of 14 cases.
    Bekers EM; Groenen PJTA; Verdijk MAJ; Raaijmakers-van Geloof WL; Roepman P; Vink R; Gilhuijs NDB; van Gorp JM; Bovée JVMG; Creytens DH; Flanagan AM; Suurmeijer AJH; Mentzel T; Arbajian E; Flucke U
    Genes Chromosomes Cancer; 2017 Oct; 56(10):750-757. PubMed ID: 28639284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell line.
    de Jong Y; van Maldegem AM; Marino-Enriquez A; de Jong D; Suijker J; Briaire-de Bruijn IH; Kruisselbrink AB; Cleton-Jansen AM; Szuhai K; Gelderblom H; Fletcher JA; Bovée JV
    Lab Invest; 2016 Oct; 96(10):1128-37. PubMed ID: 27617402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Extraskeletal mesenchymal chondrosarcoma in central nerve system: a clinicopathological analysis].
    Wang YJ; Wang LM; Meng YH; Qi CH; Zhao LH; Lu DH; Teng LH
    Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1157-1162. PubMed ID: 34619870
    [No Abstract]   [Full Text] [Related]  

  • 39. Repurposing Ponatinib as a Potent Agent against
    Han Y; Gu Z; Wu J; Huang X; Zhou R; Shi C; Tao W; Wang L; Wang Y; Zhou G; Li J; Zhang Z; Sun S
    Theranostics; 2019; 9(7):1952-1964. PubMed ID: 31037149
    [No Abstract]   [Full Text] [Related]  

  • 40. The Differences Between Intracranial Mesenchymal Chondrosarcoma and Conventional Chondrosarcoma in Clinical Features and Outcomes.
    Ma X; Meng G; Wang K; Li D; Wang L; Li H; Zhang J; Zhang L; Wu Z
    World Neurosurg; 2019 Feb; 122():e1078-e1082. PubMed ID: 30415056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.